Abstract:Adenoid cystic carcinoma (ACC) is the second most common malignancy of the salivary glands, also found at lower frequency rates in other secretory glands such as the mammary and lacrimal glands. Salivary ACCs are slow-growing but aggressive neoplasms, with propensity to perineural invasion and high recurrence rates. MYB is the most frequently altered gene in ACCs, as approximately 40% of the ACCs contain MYB-NFIB gene fusions, and the full-length MYB is overexpressed in over 50% of the fusion-negative ACCs. However, it is still unclear whether MYB activities promote ACC development. To assess the oncogenic potential of MYB in vivo, we generated transgenic mice that overexpress MYB using the TetO system. In these mice, focal MYB overexpression was directed to salivary and mammary glands using the activator line MMTV-tTA. We found that 25% of these mice developed tumors with an average latency of 23 months. Remarkably, all the tumors that developed in these mice were ACCs, and the three main phenotypic variants of human ACCs (cribriform, tubular and solid) were represented in this cohort. Using the same transgenic system, we found that the MYB-NFIB fusion also induced ACCs, with similar incidence and lower latency. Immunohistochemical analysis of these mouse ACCs for several biomarkers of human ACC, including p63 and c-kit, provided additional evidence of the similarity of the mouse ACCs that developed in these models, and human ACCs. RNAseq global expression profiling uncovered the activation of several cancer-associated pathways in MYB-induced mouse ACCs. Most notably, activation NOTCH signaling was highly enriched in these tumors. Additional analysis for the presence of the NOTCH intracellular domain demonstrated that all of the MYB- and MYB-NFIB-induced ACCs contain NOTCH activation. These findings, and the recent identification of activating mutations in NOTCH1 and NOTCH2 in human ACCs, suggest that NOTCH activities may contribute to ACC development. To test this hypothesis, ongoing studies in the lab are directed to assess the role of NOTCH signaling in ACC development, by generating mouse models in which constitutive activation of NOTCH is induced in mice alone or in combination with MYB alterations. Overall, these studies demonstrate that MYB activities are the main oncogenic driver of ACC. Genomic rearrangements that result in MYB-NFIB fusions may enhance the oncogenic potential of MYB. Citation Format: Yuan Hu, Xiaoyuan Zhu, Han Luo, Adel El-Naggar, Carlos Caulin. MYB and the MYB-NFIB fusion induce adenoid cystic carcinoma [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 1611.

A Unifying Gene Signature for Adenoid Cystic Cancer Identifies Parallel MYB-dependent and MYB-independent Therapeutic Targets.

Abstract 1611: MYB and the MYB-NFIB Fusion Induce Adenoid Cystic Carcinoma

Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets

Transcriptome Analyses Identify Hub Genes and Potential Mechanisms in Adenoid Cystic Carcinoma.

Identification and Functional Analysis of Novel Biomarkers in Adenoid Cystic Carcinoma.

MYB-activated Models for Testing Therapeutic Agents in Adenoid Cystic Carcinoma.

Transcriptomic Insights into Adenoid Cystic Carcinoma Via RNA Sequencing.

Abstract PR07: Oncogene addition to MYB-NFIB in adenoid cystic carcinomas induced in transgenic mice

Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance

Tumour Immune Characterization in Adenoid Cystic Carcinoma Identifies Prognostic and Immunotherapeutically Relevant Messenger RNA Signatures.

Comprehensive and In-Depth Analysis of Microrna and Mrna Expression Profile in Salivary Adenoid Cystic Carcinoma.

Abstract 1922: MYB Mimic Peptides Targeting Human and Murine MYB-NFIB Positive Tumor Cells

Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome

Comparative Analysis of MYB Expression by Immunohistochemistry and RNA Sequencing in Clinical Gene Fusion Detection in Adenoid Cystic Carcinoma

Molecular Analysis of Salivary and Lacrimal Adenoid Cystic Carcinoma

Identification of Pivotal Micrornas Involved in the Development and Progression of Salivary Adenoid Cystic Carcinoma

Identification of MicroRNA Expression Profiles Related to the Aggressiveness of Salivary Gland Adenoid Cystic Carcinomas

MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma

The Expression of MACC1 and Its Role in the Proliferation and Apoptosis of Salivary Adenoid Cystic Carcinoma.

Reconstruction and Analysis of the Aberrant Lncrna-Mirna-mrna Network Based on Competitive Endogenous RNA in Adenoid Cystic Carcinoma of the Salivary Gland

Circulating Adenoid Cystic Carcinoma associated MYB transcripts enable rapid and sensitive detection of metastatic disease in blood liquid biopsies